NCT00448344 Family-supported Smoking Cessation for Chronically Ill Veterans Status COMPLETED Phase NA
NCT00408434 Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT00408018 Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms Status TERMINATED Phase PHASE1
NCT00407498 Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms Status COMPLETED Phase PHASE1
NCT00321958 Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer Status TERMINATED Phase N/A
NCT00283465 A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy Status COMPLETED Phase PHASE4
NCT00270166 The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy Status COMPLETED Phase PHASE3
NCT00270127 Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy Status COMPLETED Phase PHASE3
NCT00226005 PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00199836 A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. Status COMPLETED Phase PHASE1
NCT00143533 Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors Status COMPLETED Phase PHASE1
NCT00105599 Effectiveness of the FairCare System for Patients With Advanced Illness Status COMPLETED Phase PHASE2
NCT00100139 Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00083720 Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy Status COMPLETED Phase PHASE2
NCT00080418 Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00026936 A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning Status COMPLETED Phase PHASE2